Although participants with egg allergies were excluded from the trial, an exploratory analysis was conducted of the pretreatment serum total IgE and anti-IgE antibody (mainly anti-ovalbumin) levels in the 24 participants in the multiple-dose part of the trial. The gene discussed is IGHE; the disease is egg allergy.